NCT03527095View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 5, 2018

Primary Completion Date

June 21, 2018

Study Completion Date

June 21, 2018

Conditions
Cystic Fibrosis
Interventions
DRUG

FDL169

CFTR corrector

Trial Locations (1)

NG11 6JS

Quotient Sciences, Ruddington

All Listed Sponsors
lead

Flatley Discovery Lab LLC

OTHER

NCT03527095 - A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects | Biotech Hunter | Biotech Hunter